Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_provenance.
- NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_assertion description "[Interestingly, reducing ChREBP(OG) levels via OGA overexpression decreased lipogenic protein content (ACC, FAS), prevented hepatic steatosis, and improved the lipidic profile of OGA-treated db/db mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_provenance.
- NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_assertion evidence source_evidence_literature NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_provenance.
- NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_assertion SIO_000772 21471514 NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_provenance.
- NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_assertion wasDerivedFrom befree-20140225 NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_provenance.
- NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_assertion wasGeneratedBy ECO_0000203 NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP555594.RAM2HD2Uj4Wdlbv1wOcW4CrSbZp-iroQc-BzTS8nxybSw130_provenance.